TOLREMO therapeutics

TOLREMO has created ground-breaking scientific knowledge that allows it to pursue its passion to discover and develop novel targeted therapeutics that will meaningfully extend the lives of patients suffering from cancer. TOLREMO therapeutics AG (“TOLREMO”) is a privately held research-stage biotechnology company. TOLREMO was founded in March 2017 as an ETH Spin-off by Dr. Stefanie Flückiger-Mangu...